Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Abortion, Complications : Article by

Quick Find
Authors & Editors
Introduction
Clinical
Differentials
Workup
Treatment
Medication
Follow-up
Miscellaneous
References

Related Articles
Abortion, Complete

Abortion, Incomplete

Abortion, Inevitable

Abortion, Missed

Abortion, Septic

Abortion, Threatened

Appendicitis, Acute

Dysfunctional Uterine Bleeding

Dysmenorrhea

Ovarian Cysts

Ovarian Torsion

Pregnancy, Ectopic

Pregnancy, Trauma

Pregnancy, Urinary Tract Infections

Trauma, Lower Genitourinary

Urinary Tract Infection, Female

Vaginitis

Vulvovaginitis




Patient Education
Pregnancy and Reproduction Center

Procedures Center

Miscarriage Overview

Miscarriage Causes

Miscarriage Symptoms

Miscarriage Treatment

Abortion Introduction

Abortion Preparation

Dilation and Curettage (D&C) Introduction

Dilation and Curettage (D&C) Preparation




Author: Slava V Gaufberg, MD, Assistant Professor of Medicine, Harvard Medical School; Associate Chief, Research Director, Director of Education and Training, Department of Emergency Medicine, The Cambridge Hospital

Slava V Gaufberg is a member of the following medical societies: American College of Emergency Physicians

Editors: Roy Alson, MD, PhD, FACEP, FAAEM, Associate Professor, Department of Emergency Medicine, Wake Forest University School of Medicine; Medical Director, Forsyth County EMS; Deputy Medical Advisor, North Carolina Office of EMS; Associate Medical Director, North Carolina Baptist AirCare; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Mark Zwanger, MD, MBA, Assistant Professor, Department of Emergency Medicine, Thomas Jefferson University; John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center; Pamela L Dyne, MD, Associate Professor, Program Director, Department of Medicine, Division of Emergency Medicine, University of California at Los Angeles School of Medicine

Author and Editor Disclosure

Synonyms and related keywords: miscarriage, spontaneous abortion, therapeutic abortion, postabortion complications, post-abortion complications, complications of anesthesia, postabortion triad, pain, bleeding, low-grade fever, hematometra, retained products of conception, uterine perforation, bowel and bladder injury, failed abortion, septic abortion, cervical shock, cervical laceration, disseminated intravascular coagulation, DIC, complications of abortion

Background

Complications of spontaneous and therapeutic abortions include (1) complications of anesthesia, (2) postabortion triad (ie, pain, bleeding, low-grade fever), (3) hematometra, (4) retained products of conception, (5) uterine perforation, (6) bowel and bladder injury, (7) failed abortion, (8) septic abortion, (9) cervical shock, (10) cervical laceration, and (11) disseminated intravascular coagulation (DIC).

Pathophysiology

Postabortion complications develop as a result of 3 major mechanisms, as follows: (1) incomplete evacuation of the uterus and uterine atony, which leads to hemorrhagic complications, (2) infection, and (3) instrumental injury.

Frequency

United States

Frequency depends on gestational age (GA) at time of abortion and method of abortion. Complication rates according to GA at time of abortion are as follows: (1) fewer than 6 weeks, less than 1%; (2) 12-13 weeks, 3-6%; and (3) second trimester, up to 50%, possibly higher.

Mortality/Morbidity

Mortality and morbidity depend on GA at time of abortion. In the US, mortality rates per 100,000 abortions are as follows: (1) fewer than 8 weeks, 0.5; (2) 11-12 weeks, 2.2; (3) 16-20 weeks, 14; and (4) more than 21 weeks, 18.



History

Presentation depends on the type of complication the patient develops.

  • Intraoperative and early postoperative complications rarely are seen in the ED, but some patients develop these types of complications and present to the ED for treatment. Complications include the following:
    • Local anesthesia: Paracervical block is the most common method of anesthesia for therapeutic abortion. Accidental intravascular injection of anesthetic is a potentially life-threatening complication of this method that could lead to convulsion, cardiopulmonary arrest, and death.
    • General anesthesia: Complications with general anesthesia may lead to uterine atony with severe hemorrhage.
    • Cervical shock: Vasovagal syncope produced by stimulation of the cervical canal during dilatation may occur. Rapid recovery usually follows.
    • Postabortion triad: Pain, bleeding, and low-grade fevers are the most common presenting complaints. Postabortion triad usually is caused by retained products of conception.
    • Hemorrhage: Excessive hemorrhage during or after abortion may signify uterine atony, cervical laceration, uterine perforation, cervical pregnancy, a more advanced GA than anticipated, or coagulopathy.
    • Hematometra: Patients usually present with persistent postabortion bleeding and increased lower midline abdominal pain.
    • Perforation: Patients with uterine perforation missed during the procedure usually present to the ED with increased abdominal pain, bleeding (possibly ranging from very mild to absent), and fever. If perforation results in injury to major blood vessels, patients may present in hemorrhagic shock.
    • Bowel injury: This may accompany uterine perforation. If initially unrecognized, patients present with abdominal pain, fever, blood in the stool, nausea, and vomiting.
    • Bladder injury: This occurs as a result of uterine or cervical perforation. Patients present with suprapubic pain and hematuria.
    • Septic abortion: Patients present with fever, chills, abdominal pain, and vaginal bleeding.
    • Failed abortion (continued intrauterine or ectopic pregnancy): Failure to terminate pregnancy is relatively common with very early abortions ( <6 wk GA). Such patients may present to the ED with symptoms of continuing pregnancy such as hyperemesis, increased abdominal girth, and breast engorgement. In addition, an unrecognized ectopic pregnancy in the postabortion period presents in the usual manner.
    • DIC: Suspect DIC in all patients who present with severe postabortion bleeding, especially after midtrimester abortions. Incidence is approximately 200 cases per 100,000 abortions; this rate is even higher for saline instillation techniques (660 per 100,000 abortions).

Physical

  • Vital signs
    • Monitoring of vital signs is essential for patients with postabortion complications.
    • Increasing fever could be a sign of progressing infection.
    • Tachycardia and hypotension may be signs of severe hemorrhage or septic shock.
  • Abdominal examination
    • Suprapubic tenderness is common in the postabortion period. Severe tenderness is unusual, however, and may be a sign of hematometra, bladder perforation, or bowel injury.
    • Tenderness in other areas of the abdomen (eg, rebound tenderness, guarding) strongly indicates instrumental injury complications (eg, perforation, bowel injury, bladder injury).
    • A tender mass in suprapubic area suggests hematometra.
    • Diminished or absent bowel sounds are a sign of developing peritonitis.
  • Vaginal examination
    • Assess the quantity and rate of hemorrhage.
      • Look for possible vaginal or cervical injury.
      • Identify the source of bleeding (eg, intrauterine, cervical os, lesions of vulva, vagina, or vaginal portion of cervix).
    • Cervical motion tenderness on bimanual examination may be suggestive of pelvic infection or ectopic pregnancy.
    • A large tender uterus may be a sign of hematometra.
    • Adnexal tenderness or masses may suggest ectopic pregnancy, pelvic inflammatory disease (PID), cyst, or hematoma.
  • Rectal examination
    • Rectal examination must be performed if bowel injury is suspected.
    • Presence of rectal tenderness and blood (or guaiac-positive stool) makes the diagnosis of bowel injury almost certain.



Abortion, Complete
Abortion, Incomplete
Abortion, Inevitable
Abortion, Missed
Abortion, Septic
Abortion, Threatened
Appendicitis, Acute
Dysfunctional Uterine Bleeding
Dysmenorrhea
Ovarian Cysts
Ovarian Torsion
Pregnancy, Ectopic
Pregnancy, Trauma
Pregnancy, Urinary Tract Infections
Trauma, Lower Genitourinary
Urinary Tract Infection, Female
Vaginitis
Vulvovaginitis

Other Problems to be Considered

Perforated viscus
Acute peritonitis



Lab Studies

  • Complete blood count, platelets
  • Sequential Multiple Analysis-7
  • Beta-human chorionic gonadotropin; requesting a quantitative level may provide useful information and a basis for future comparison.
  • Prothrombin time/activated partial thromboplastin time
  • Urinalysis
  • Type and screen or type and cross with antibody screen (with severe hemorrhage)
  • Fibrinogen and fibrin split products if DIC is suspected
  • D-dimer

Imaging Studies

  • To exclude free air as a result of bowel perforation, perform either upright chest x-ray or obtain kidney, ureter, bladder (KUB) and upright abdominal x-rays.
  • Order or perform ultrasound with a vaginal probe to rule out ectopic pregnancy, retained products of conception, and hematometra.
  • Order arteriography if injury to large blood vessels is suspected.



Prehospital Care

Monitor vital signs and provide fluid resuscitation if the patient is hemodynamically unstable.

Emergency Department Care

Screen all patients with postabortion complications for Rh factor. Administer Rho(D) immune globulin (RhoGAM) if results indicate that the patient is Rh-negative and unsensitized.

  • Patients with the postabortion triad (ie, pain, bleeding, low-grade fever) may respond to treatment with oral antibiotics and ergot preparations. Immediately initiate these agents. In most cases, however, blood clots or retained products of conception must be evacuated from the uterus. In these cases, administer medications parenterally, as the patient will undergo anesthesia.
  • Hemorrhage or hematometra
    • Monitor vital signs and rate of bleeding. Administer fluids and blood as needed.
    • Administer IV oxytocin for treatment of uterine atony.
    • Alternative treatments for uterine atony include intracervical vasopressin or carboprost tromethamine and bimanual uterine massage.
    • If bleeding persists, screen for coagulopathy/DIC and obtain immediate gynecologic consultation with the intention of transferring the patient to the operating room (OR) for repeat curettage and, if necessary, hysterectomy.
  • Uterine perforation, bowel injury, and bladder injury: If one or any combination of these complications is suspected or diagnosed in the ED, treat as follows.
    • Hemodynamically stabilize the patient.
    • Insert a Foley catheter.
    • Transfer to the OR for laparoscopy/laparotomy and further treatment.
  • Failed abortion, continued pregnancy, and ectopic pregnancy
    • If the patient is stable, perform ultrasound and a beta-human chorionic gonadotropin (hCG) test to establish diagnosis and further treatment.
    • If the patient is unstable, transfer to the OR for dilation and curettage (D&C) and/or laparoscopy/laparotomy.

Consultations

  • Consult an obstetrician/gynecologist (OB/GYN) in all cases of postabortion complications.
  • Consult surgery and urology if bowel or bladder injury is diagnosed.



The goals of pharmacotherapy are to eradicate the infection, reduce morbidity, and prevent complications.

Drug Category: Antibiotics

Immediately administer broad-spectrum antibiotics to patients with severe postabortion infection.

Drug NameCefoxitin (Mefoxin)
DescriptionIndicated for infections caused by susceptible gram-positive cocci and gram-negative bacilli. Many infections caused by gram-negative bacteria resistant to some cephalosporins and penicillins respond to cefoxitin.
Adult Dose2 g IV q6h and 100 mg IV doxycycline q12h; continue at least 4 d and at least 48 h after improvement; then 100 mg PO doxycycline bid 10-14 d
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity
InteractionsProbenecid may increase effects of cefoxitin; coadministration with aminoglycosides or furosemide may increase nephrotoxicity (closely monitor renal function)
PregnancyB - Usually safe but benefits must outweigh the risks.
PrecautionsBacterial or fungal overgrowth of nonsusceptible organisms may occur with prolonged use or repeated treatment; caution in patients with previously diagnosed colitis

Drug NameDoxycycline (Bio-Tab, Doryx, Vibramycin)
DescriptionTreats infections caused by susceptible gram-negative and gram-positive organisms, in addition to infections caused by susceptible Rickettsia, Chlamydia, and Mycoplasma species.
Adult Dose100 mg IV q12h and 2 g IV cefoxitin q6h; continue at least 4 d and at least 48 h after patient improves; then 100 mg PO doxycycline bid 10-14 d
Pediatric Dose<12 years: Not established
>12 years: Administer as in adults
ContraindicationsDocumented hypersensitivity, severe hepatic dysfunction
InteractionsBioavailability decreases with antacids containing Al, Ca, Mg, Fe, or Bi subsalicylate; tetracyclines can increase hypoprothrombinemic effects of anticoagulants; tetracyclines can decrease effects of PO contraceptives, causing breakthrough bleeding and increased risk of pregnancy
PregnancyD - Unsafe in pregnancy
PrecautionsPhotosensitivity may occur with prolonged exposure to sunlight or tanning equipment; reduce dose in renal impairment; consider drug serum level determinations in prolonged therapy; tetracycline use during tooth development (last half of pregnancy through age 8 y) can cause permanent discoloration of teeth; Fanconilike syndrome may occur with outdated tetracyclines

Drug NameGentamicin sulfate (Garamycin, Gentacidin)
DescriptionAminoglycoside antibiotic for gram-negative coverage. Used in combination with both an agent against gram-positive organisms and an agent that covers anaerobes. Not the DOC. Consider if penicillins (see note above) or other less toxic drugs are contraindicated, when clinically indicated, and in mixed infections caused by susceptible staphylococci and gram-negative organisms. Dosing regimens are numerous; adjust dose based on CrCl and changes in volume of distribution. May be administered IV/IM.
Adult DoseSerious infections and normal renal function: 3 mg/kg/d IV q8h; monitor renal levels
Life-threatening infections: 5 mg/kg/d IV q6-8h; monitor renal levels
Maintenance dose: 1-2.5 mg/kg IV and 1-1.5 mg/kg IV, respectively, q8h; monitor renal levels
Pediatric Dose>12 years: 1.5-2.5 mg/kg/dose IV q8h or 6-7.5 mg/kg/d IV divided q8h; not to exceed 300 mg/d; monitor renal levels, adjust for renal function as needed; monitor renal levels as in adults
ContraindicationsDocumented hypersensitivity, non–dialysis-dependent renal insufficiency
InteractionsCoadministration with other aminoglycosides, cephalosporins, penicillins, and amphotericin B may increase nephrotoxicity; aminoglycosides enhance effects of neuromuscular blocking agents; thus, prolonged respiratory depression may occur; coadministration with loop diuretics may increase auditory toxicity of aminoglycosides; possible irreversible hearing loss of varying degrees may occur (monitor regularly)
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsNarrow therapeutic index (not intended for long-term therapy); caution in renal failure (not on dialysis), myasthenia gravis, hypocalcemia, and conditions that depress neuromuscular transmission; adjust dose in renal impairment

Drug NameTicarcillin and clavulanate potassium (Timentin)
DescriptionPresumptive therapy prior to identification of organism. Inhibits biosynthesis of cell wall mucopeptide; effective during stage of active growth.
Adult Dose<60 kg: 200-300 mg/kg/d IV divided q4-6h
>60 kg: 3.1 g IV q4-6h or 200-300 mg/kg/d in equally divided doses q4-6h; not to exceed 18-24 g/d
Pediatric DoseAdminister as in adults
ContraindicationsDocumented hypersensitivity; severe pneumonia, bacteremia, pericarditis, emphysema, meningitis, and purulent or septic arthritis should not be treated with PO penicillins during acute stage
InteractionsTetracyclines may decrease effects; high concentrations of ticarcillin may physically inactivate aminoglycosides if administered in same IV line; effects when administered concurrently with aminoglycosides are synergistic; probenecid may increase penicillin levels
PregnancyB - Usually safe but benefits must outweigh the risks.
PrecautionsPerform CBCs prior to initiation of therapy and at least weekly during therapy; monitor for liver function abnormalities by measuring AST and ALT during therapy; exercise caution in patients diagnosed with hepatic insufficiencies; perform UA and BUN and creatinine determinations during therapy and adjust dose if values become elevated; monitor blood levels to avoid possible neurotoxic reactions

Drug NameAmpicillin and sulbactam sodium (Unasyn)
DescriptionDrug combination of beta-lactamase inhibitor with ampicillin. Covers skin, enteric flora, and anaerobes. Not ideal for nosocomial pathogens.
Adult Dose1.5 (1 g ampicillin + 0.5 g sulbactam) to 3 g (2 g ampicillin + 1 g sulbactam) IV/IM q6-8h; not to exceed 4 g/d sulbactam
Pediatric DoseNot established for pediatric patients with intra-abdominal infections
>40 kg: Administer as in adults
ContraindicationsDocumented hypersensitivity
InteractionsProbenecid and disulfiram elevate ampicillin levels; allopurinol decreases ampicillin effects and has additive effects on ampicillin rash; may decrease effects of PO contraceptives
PregnancyB - Usually safe but benefits must outweigh the risks.
PrecautionsAdjust dose in renal failure; evaluate rash and differentiate from hypersensitivity reaction

Drug NameImipenem and cilastatin sodium (Primaxin)
DescriptionTreats multiple-organism infections for which other agents lack wide-spectrum coverage or are contraindicated due to potential toxicity.
Adult Dose250-500 mg IV divided q6h; not to exceed 3-4 g/d, based on severity of infection
Alternatively, administer 500-750 mg IM or intra-abdominally q12h
Pediatric Dose15-25 mg/kg/dose IV q6h; maximum daily dose for fully susceptible organisms is 2 g/d; for infections with moderately susceptible organisms, maximum dose is 4 g/d
ContraindicationsDocumented hypersensitivity
InteractionsCoadministration with cyclosporine may increase CNS adverse effects of both agents; coadministration with ganciclovir may result in generalized seizures
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsAdjust dose in renal insufficiency

Drug NamePiperacillin and tazobactam sodium (Zosyn)
DescriptionTreats septicemia caused by susceptible organisms.
Adult Dose12 g piperacillin + 1.5 g tazobactam IV in equally divided doses of 3 g q6h for 7-10 d
Pediatric Dose<12 years: Not established
>12 years: Administer as in adults
ContraindicationsDocumented hypersensitivity
InteractionsTetracyclines may decrease effects of ticarcillin; high concentrations of ticarcillin may physically inactivate aminoglycosides if administered in same IV line; effects when administered concurrently with aminoglycosides are synergistic; probenecid may increase penicillin levels
PregnancyB - Usually safe but benefits must outweigh the risks.
PrecautionsPerform CBCs prior to initiation of therapy and at least weekly during therapy; monitor for liver function abnormalities by measuring AST and ALT during therapy; exercise caution in patients diagnosed with hepatic insufficiencies; perform UA and BUN and creatinine determinations during therapy and adjust dose if values become elevated; monitor blood levels to avoid possible neurotoxic reactions

Drug NameClindamycin (Cleocin)
DescriptionUseful as treatment against aerobic streptococci and most staphylococci. Inhibits bacterial growth, possibly by blocking dissociation of peptidyl t-RNA from ribosomes, causing RNA-dependent protein synthesis to arrest.
Adult DoseSerious infections due to aerobic and anaerobic organisms: 600-1200 mg/d IV divided q6-8h
Pediatric Dose8-16 mg/kg/d IV divided tid/qid
Severe infections: 16-20 mg/kg/d divided tid/qid
ContraindicationsDocumented hypersensitivity; pseudomembranous colitis; hepatic impairment
InteractionsIncreases duration of neuromuscular blockade, induced by tubocurarine and pancuronium; erythromycin may antagonize effects; antidiarrheals may delay absorption
PregnancyB - Usually safe but benefits must outweigh the risks.
PrecautionsAdjust dose in severe hepatic dysfunction; no adjustment necessary in renal insufficiency; associated with severe and possibly fatal colitis

Drug NameCefotaxime (Claforan)
DescriptionTreats septicemia and gynecologic infections caused by susceptible organisms. Arrests bacterial cell wall synthesis, which in turn inhibits bacterial growth.
Adult DoseModerate-to-severe infections: 1-2 g IV/IM q6-8h
Life-threatening infections: 1-2 g IV/IM q4h
Pediatric Dose<12 years: Not established
>12 years: Administer as in adults
ContraindicationsDocumented hypersensitivity
InteractionsProbenecid may increase cefotaxime levels; coadministration with furosemide and aminoglycosides may increase nephrotoxicity
PregnancyB - Usually safe but benefits must outweigh the risks.
PrecautionsAdjust dose in severe renal impairment; has been associated with severe colitis

Drug NameVancomycin HCL (Vancocin, Vancoled)
DescriptionPotent antibiotic directed against gram-positive organisms and active against enterococcal species. Useful in the treatment of septicemia and skin structure infections. Indicated for patients who cannot receive or have failed to respond to penicillins and cephalosporins or who have infections with resistant staphylococci. To avoid toxicity, current recommendation is to assay only vancomycin trough levels after the third dose, drawn 0.5 h before next dosing. Doses and dosing intervals may be adjusted based on CrCl.
Adult Dose500 mg/d to 2 g/d IV tid/qid for 7-10 d
Pediatric Dose40 mg/kg/d IV divided tid/qid for 7-10 d
ContraindicationsDocumented hypersensitivity
InteractionsErythema, histaminelike flushing and anaphylactic reactions may occur when administered with anesthetic agents; taken concurrently with aminoglycosides, risk of nephrotoxicity may increase above that with aminoglycoside monotherapy; effects in neuromuscular blockade may be enhanced when coadministered with nondepolarizing muscle relaxants
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsCaution in renal failure, neutropenia; "red man" syndrome is caused by too rapid IV infusion (dose administered over a few min) but rarely happens when dose given as 2-h administration or as PO or IP administration; red man syndrome is not an allergic reaction

Drug Category: Ergot alkaloids

Ergot derivatives are used for oxytocic effects on uterine muscle. These agents prevent postabortion uterine atony and hemorrhage.

Drug NameErgonovine maleate (Ergotrate Maleate)
DescriptionPrevents and treats postabortal hemorrhage due to uterine atony by producing a firm contraction of the uterus within minutes. Although intended primarily for IM administration, faster response can be achieved through IV administration. However, because IV route produces higher incidence of adverse effects, reserve for emergencies such as excessive uterine bleeding. Severe uterine bleeding may require repeated doses but seldom requires more than 1 injection q2-4h.
Adult Dose0.2 mg IM/IV repeat q2-4h if needed
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity, not to be used in cases of threatened spontaneous abortion
InteractionsConcurrent administration of methylergonovine with vasoconstrictors or other ergot alkaloids may produce additive effect
PregnancyX - Contraindicated in pregnancy
PrecautionsDiscontinue if ergotism develops; caution in heart disease, hypertension, mitral-valve stenosis, venoatrial shunts, sepsis, obliterative vascular disease, or hepatic or renal impairment

Drug NameMethylergonovine (Methergine)
DescriptionActs directly on the smooth muscle of the uterus; induces a rapid and sustained tetanic uterotonic effect that reduces bleeding.
Adult Dose0.2 mg IM
Severe uterine bleeding: Repeat doses q2-4h; same dose may be administered IV to produce quicker response; however, because IV route produces higher incidence of adverse effects, reserve for emergencies such as excessive uterine bleeding
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity, glaucoma, Tourette syndrome, anxiety
InteractionsConcurrent administration of methylergonovine with vasoconstrictors or other ergot alkaloids may produce additive effect
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsCaution in sepsis, obliterative vascular disease, or hepatic or renal insufficiency



Further Inpatient Care

  • Inpatient treatment includes repeat D&C, laparoscopy, and laparotomy (for treatment of complicated perforation, bowel and bladder injuries, refractory bleeding).

Further Outpatient Care

  • If the patient is discharged from the ED, arrange definite follow-up care in 1-2 days with primary gynecologist.

Deterrence/Prevention

  • Educate patients about contraceptive measures to deter them from using abortion as a means of birth control.

Patient Education



Medical/Legal Pitfalls

  • Do not underestimate the amount and rate of bleeding. In the supine position, more than 500 cc of blood may collect in the vagina without severe external bleeding. Always perform a pelvic examination on a postabortion patient who is bleeding.
  • Aggressively treat vaginal bleeding even if it seems minimal. Stabilize the patient with 2 large-bore IVs and with oxygen. Closely monitor vital signs.
  • In postabortion patients with abdominal pain beyond the pelvic area, suspect perforation and evaluate with KUB/upright x-rays and pelvic ultrasound. Consult a gynecologist and, if suspicion is high, insist on laparoscopy.
  • The chance of a missed ectopic pregnancy always exists. Do not presume intrauterine pregnancy in a patient who has just had an abortion; she may have had a missed ectopic pregnancy.
  • Do not delay administration of antibiotics if a patient has signs of severe postabortion infection. Administer broad-spectrum antibiotics before completing diagnostic workup.



  • Darney PD, ed. Handbook of Office and Ambulatory Gynecologic Surgery. Blackwell Science, Inc;1987:108.
  • Grimes DA, Cates W Jr. Deaths from paracervical anesthesia used for first-trimester abortion, 1972-1975. N Engl J Med. Dec 16 1976;295(25):1397-9. [Medline].
  • Hakim-Elahi E, Tovell HM, Burnhill MS. Complications of first-trimester abortion: a report of 170,000 cases. Obstet Gynecol. Jul 1990;76(1):129-35. [Medline].
  • Sam C, Hamid MA, Swan N. Pyometra associated with retained products of conception. Obstet Gynecol. May 1999;93(5 Pt 2):840. [Medline].
  • Shannon C, Brothers LP, Philip NM, Winikoff B. Infection after medical abortion: a review of the literature. Contraception. Sep 2004;70(3):183-90. [Medline].
  • Shulman SG, Bell CL, Hampf FE. Uterine perforation and small bowel incarceration: sonographic and surgical findings. Emerg Radiol. Aug 16 2006;[Medline].
  • Stuart GS, Sheffield JS, Hill JB, et al. Morbidity that is associated with curettage for the management of spontaneous and induced abortion in women who are infected with HIV. Am J Obstet Gynecol. Sep 2004;191(3):993-7. [Medline].
  • Stubblefield PG. First and second trimester abortion. In: Nichols DH, ed. Gynecologic and Obstetric Surgery. Mosby-Year Book;1993:1016-1030.
  • Stubblefield PG, Grimes DA. Septic abortion. N Engl J Med. Aug 4 1994;331(5):310-4. [Medline].
  • Stubblefield PG. Pregnancy termination. In: Obstetrics: Normal and Problem Pregnancies. 3rd ed. Churchill Livingstone;1996:1249-1276.

Abortion, Complications excerpt

Article Last Updated: Aug 29, 2006